Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
Predicting early signs of dyslexia at a preliterate age by combining behavioral assessment with structural MRI.
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients.
Peripheral Inflammation and Demyelinating Diseases.
Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.
Current Evidence Does Not Support Exercise Therapy for Perceived Fatigue in Multiple Sclerosis.
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes.
Blink reflex role in algorithmic genetic testing of inherited polyneuropathies.
Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.
Maternal chewing during prenatal stress ameliorates stress-induced hypomyelination, synaptic alterations, and learning impairment in mouse offspring.
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders.
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.
Differential Regulation of Self-reactive CD4(+) T Cells in Cervical Lymph Nodes and Central Nervous System during Viral Encephalomyelitis.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.
Rituximab for treating multiple sclerosis: Off-label but on target.
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
Trifluoperazine: A Sprightly Old Drug.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Pancolitis a novel early complication of Alemtuzumab for MS treatment.
Diffusion tensor imaging with direct cytopathological validation: characterisation of decorin treatment in experimental juvenile communicating hydrocephalus.
Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study.

Pages